Patent · US Expired

Method and composition for treating thrombosis

US5672585A · kind A · utility

62Cited by
16References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 22, 1995
Grant dateSep 30, 1997
Priority date
Expiry dateMay 22, 2015

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides cyclic peptides which inhibit platelet aggregation without causing prolonged bleeding time. The invention provides RGD or KGD containing peptides which are cyclized and contain hydrophobic amino acids adjacent to the carboxy terminus of the RGD sequence. Peptides of this nature are also provided which contain in addition to the hydrophobic amino acid an adjacent positively charged amino acid. Such peptides have a high affinity for the receptor IIb/IIIa and a low affinity for the fibronectin and vitronectin receptors. Such peptides can be administered in a suitable physiologically acceptable carrier to therapeutically treat thrombosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.